Laboratory For Advanced Medicine Appoints New CEO, Prepares To Scale Liquid Biopsy Pipeline
With a new CEO at its helm, Laboratory for Advanced Medicine is preparing to take on the cancer-diagnostics market. Former AncestryDNA executive Kenneth Chahine has joined the company as it plans to drive global commercialization of its artificial intelligence liquid biopsy pipeline.
You may also be interested in...
Belgian start-up miDiagnostics has closed a €14m investment round to accelerate development of its silicon-chip-based diagnostics platform. The company believes the blood analyzer could deliver rapid test results in multiple settings.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
The UK government has ordered 3.5 million home test kits to identify people who have antibodies to the SARS-CoV-2 virus. However, it has not said who will supply the test kits.